EnWave (ENW) Planet MicroCap Showcase summary
Event summary combining transcript, slides, and related documents.
Planet MicroCap Showcase summary
3 Feb, 2026Business overview and technology
Commercialization of patented vacuum microwave dehydration technology with over 50 global partners, mainly in the food sector, generating both machinery sales and royalties.
Revenue has been stable at CAD 10–12 million annually, with 85–90% from machinery sales and 30% gross margin; royalties are a growing secondary stream.
Cash position exceeds CAD 4 million, eliminating the need for near-term capital raises.
Focus has shifted away from cannabis to food, with a blue-sky opportunity in pharmaceuticals via a partnership with GEA Lyophil.
Technology offers faster, more efficient dehydration than freeze or air drying, with significant ESG benefits and the ability to upcycle lower-grade food products.
Market position and competitive advantage
Only provider of scalable, reliable vacuum microwave equipment, protected by 18 patents covering apparatus and processing protocols.
54 licensed partners across 25 countries, with a focus on IP-respecting jurisdictions; major clients include Dole and Calbee.
Addressable market for dehydration equipment was CAD 4.3 billion in 2023, with royalty rates typically 2–5% of gross revenue.
Royalty revenue is pure margin and expected to grow as installed base increases.
Financial performance and outlook
Fiscal 2024 royalty run rate expected at CAD 2 million, up from CAD 1.5 million in 2023; several large installations underway for further growth in fiscal 2025.
Q3 2024 saw strong revenue and margin due to multiple machine sales; Q4 is also expected to be strong.
Selling 4 large machines achieves cash flow break-even; targeting 8 machines in fiscal 2025 could yield CAD 3–4 million EBITDA.
Installed capacity projected to reach 2,700–2,800 kW by end of fiscal 2024, supporting future royalty growth.
No debt and no need for additional capital; focus is on execution and increasing market visibility.
Latest events from EnWave
- REV™ technology drives recurring royalties and global growth in food, pharma, and cannabis markets.ENW
Corporate presentation5 Mar 2026 - Revenue up 36% to CAD 1.6M, gross margin at 37%, and new license deals drive growth.ENW
Q1 202620 Feb 2026 - Accelerating royalty growth and global adoption position the business for scalable, high-margin expansion.ENW
Planet MicroCap Showcase: VEGAS 20253 Feb 2026 - Accelerating royalty growth and global expansion position the business for positive EBITDA in 2026.ENW
Planet MicroCap Showcase: TORONTO 20253 Feb 2026 - Q2 2025 revenue surged 456%, gross margin hit 33%, and EBITDA turned positive.ENW
Q2 202527 Jan 2026 - Record royalties, margin rebound, and positive EBITDA highlight strong growth momentum.ENW
Q3 202423 Jan 2026 - Q4 2024 delivered strong revenue and net income growth, with a positive outlook for 2025.ENW
Q4 202411 Jan 2026 - Higher royalties and margins offset lower sales; losses narrowed and new deals signed.ENW
Q1 202526 Dec 2025 - Record revenue and profitability in FY2025 set the stage for continued growth in 2026.ENW
Q4 202515 Dec 2025